Gastrointestinal Cancer News and Research

RSS
Gastrointestinal cancer refers to malignant conditions of the gastrointestinal tract, including the esophagus, stomach, liver, biliary system, pancreas, bowels, and anus.
Phase IIIb CONSIGN study confirms benefit of regorafenib in patients with pre-treated mCRC

Phase IIIb CONSIGN study confirms benefit of regorafenib in patients with pre-treated mCRC

SENRI Trial: NK1 antagonists may prevent emesis in patients treated with oxaliplatin-based chemotherapy

SENRI Trial: NK1 antagonists may prevent emesis in patients treated with oxaliplatin-based chemotherapy

Low BMI linked to poorer survival in advanced colorectal cancer

Low BMI linked to poorer survival in advanced colorectal cancer

Study evaluates VolitionRx's proprietary Nucleosomics platform in most prevalent cancers

Study evaluates VolitionRx's proprietary Nucleosomics platform in most prevalent cancers

Special issue of Gastroenterology highlights how food impacts health and disease

Special issue of Gastroenterology highlights how food impacts health and disease

Oncologists publish review of advanced clinical treatments for pancreatic cancer

Oncologists publish review of advanced clinical treatments for pancreatic cancer

apceth begins Agenmestencel-T Phase II clinical trial in gastrointestinal cancer patients

apceth begins Agenmestencel-T Phase II clinical trial in gastrointestinal cancer patients

Key questions about colorectal cancer answered

Key questions about colorectal cancer answered

Study discovers microRNA signatures that could predict prognosis, distant metastasis in colorectal cancer

Study discovers microRNA signatures that could predict prognosis, distant metastasis in colorectal cancer

Top cancer research and clinical developments at Dana-Farber Cancer Institute in 2014

Top cancer research and clinical developments at Dana-Farber Cancer Institute in 2014

RNF43 mutation may serve as biomarker that identifies colorectal, endometrial cancer patients

RNF43 mutation may serve as biomarker that identifies colorectal, endometrial cancer patients

Scientists discover sign of early development of pancreatic cancer

Scientists discover sign of early development of pancreatic cancer

Ramucirumab Phase III study meets primary endpoint in patients with metastatic colorectal cancer

Ramucirumab Phase III study meets primary endpoint in patients with metastatic colorectal cancer

Phase III TAS-102 study for metastatic colorectal cancer shows improved survival

Phase III TAS-102 study for metastatic colorectal cancer shows improved survival

patients with KRAS wild-type MCRC can benefit from Cetuximab Or Bevacizumab With Combi Chemo Equivalent For patients with KRAS wild-type MCRC

patients with KRAS wild-type MCRC can benefit from Cetuximab Or Bevacizumab With Combi Chemo Equivalent For patients with KRAS wild-type MCRC

Taiho Oncology presents TAS-102 Phase III RECOURSE trial results in mCRC patients

Taiho Oncology presents TAS-102 Phase III RECOURSE trial results in mCRC patients

Adding MM-398 to standard treatment improves survival in metastatic pancreatic cancer patients

Adding MM-398 to standard treatment improves survival in metastatic pancreatic cancer patients

New drug shows promising results in patients with advanced pancreatic cancer

New drug shows promising results in patients with advanced pancreatic cancer

Loyola’s Gastrointestinal Cancer Risk Assessment Program provides state-of-the-art care to cancer patients

Loyola’s Gastrointestinal Cancer Risk Assessment Program provides state-of-the-art care to cancer patients

FDA approves Cyramza to treat patients with advanced stomach cancer

FDA approves Cyramza to treat patients with advanced stomach cancer